The global cancer insurance market is forecasted to surge from $61.7 billion in 2022 to $159.9 billion by 2032, fueled by medical advancements and an aging populace. Despite high premiums hindering growth, the increasing cancer incidence presents opportunities. North America led the market in 2022, while Asia-Pacific is anticipated to witness rapid expansion. Males dominated the market in 2022, but females are projected to exhibit faster growth. Key players are innovating through new product releases to retain market share.

Cancer Insurance Market Surges Globally